Ryan Charles S.

President at Quince Therapeutics, Inc. · on record since Sep 6, 2023
Director at Polaryx Therapeutics, Inc. · on record since Jan 29, 2026
Director at BNB PLUS CORP. · on record since Dec 24, 2014
Director at BioRestorative Therapies, Inc. · on record since May 12, 2015
Director at Neurotrope, Inc. · on record since Dec 18, 2017
Chief Executive Officer at Neurotrope, Inc. · on record since Dec 17, 2018
10% owner at Neurotrope, Inc. · on record since Nov 27, 2020

Insider trading activity of Ryan Charles S.

Transactions on record: 51; since Dec 24, 2014

Open-market buys: 3; $106.5K

Open-market sells: 0

Companies traded: 4; last filing Jan 23, 2026

Figures computed from official regulatory filings — .

Companies where Ryan Charles S. has traded

Quince Therapeutics, Inc.7 tx · $41.5K · Jan 23, 2026
Neurotrope, Inc.10 tx · Dec 3, 2020
BNB PLUS CORP.9 tx · $25K · May 21, 2019
BioRestorative Therapies, Inc.25 tx · $155K · Mar 25, 2019

Track record of Ryan Charles S.

Statistical track record

Free account

Open-market buys: 5

Last buy: Aug 20, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Ryan Charles S.

Co-insiders of Ryan Charles S.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Quince Therapeutics, Inc.Listing on record	Jan 23, 2026	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 23, 2025	Award	7,548	1.20 USD	$9.1K		SEC
Quince Therapeutics, Inc.Listing on record	Jun 23, 2025	AwardD (derivative)	7,548	0.13 USD	$981.2		SEC
Quince Therapeutics, Inc.Listing on record	Feb 11, 2025	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Aug 22, 2024	Buy	48,387	0.65 USD	$31.5K	conv 69First in 12mo	SEC
Quince Therapeutics, Inc.Listing on record	Feb 2, 2024	AwardD (derivative)	145,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Sep 6, 2023	AwardD (derivative)	545,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-79,097	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-157,918	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-130,680	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Nov 27, 2020	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Neurotrope, Inc.Listing on record	Dec 16, 2019	AwardD (derivative)	130,680	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BNB PLUS CORP.Listing unverified	May 21, 2019	AwardD (derivative)	175,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	75,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	100,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-75,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	46,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-46,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Quince Therapeutics, Inc.Listing on record	Jan 23, 2026	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 23, 2025	Award	7,548	1.20 USD	$9.1K		SEC
Quince Therapeutics, Inc.Listing on record	Jun 23, 2025	AwardD (derivative)	7,548	0.13 USD	$981.2		SEC
Quince Therapeutics, Inc.Listing on record	Feb 11, 2025	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Aug 22, 2024	Buy	48,387	0.65 USD	$31.5K	conv 69First in 12mo	SEC
Quince Therapeutics, Inc.Listing on record	Feb 2, 2024	AwardD (derivative)	145,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Sep 6, 2023	AwardD (derivative)	545,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-79,097	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-157,918	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Dec 3, 2020	OtherD (derivative)	-130,680	—	n/a (No price was disclosed in the filing)		SEC
Neurotrope, Inc.Listing on record	Nov 27, 2020	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Neurotrope, Inc.Listing on record	Dec 16, 2019	AwardD (derivative)	130,680	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BNB PLUS CORP.Listing unverified	May 21, 2019	AwardD (derivative)	175,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	20,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	75,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	100,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-75,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	AwardD (derivative)	46,000	—	n/a (No price was disclosed in the filing)		SEC
BioRestorative Therapies, Inc.Listing on record	Mar 25, 2019	OtherD (derivative)	-46,000	—	n/a (No price was disclosed in the filing)		SEC